Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: cephalosporins / vancomycin / quinolones / sulfa (sulfonamides) / latex / adhesive tape / vantin / cefpodoxime attending: chief complaint: inability to decannulate trach major surgical or invasive procedure: bronchoscopy rigid bronchoscopy with y-stent placement, trach tube replacement bronchoscopy, tracheostomy tube changed to #7 cuffed history of present illness: ms. presents for evaluation of tracheobronchomalacia and possible decannulation of tracheostomy tube. past medical history: s/p trach (7 years ago, failed to extubate p hip surgery), copd, djd, mrsa pna (), vtach (), s/p multiple hip surgeries, gerd, dmii, atrial stenosis, +ab for transfusions social history: married lives with family tobacco: 30 pack-year quit family history: non-contributory physical exam: 97.1, hr 107, bp 107/60, rr17, 02 100% with trach mask general: 57 year-old female trached in no apparent distress heent; normocephalic neck: trach in place site clean dry intact, no erythema or discharge card: a-fib/a-flutter resp: breathing comforbably with trach gi: obese, bowel sounds positive, abdomen soft nt/nd extr - severe edema ble, r leg open wound w/d dressing s/p hematoma evacuation incision: rle neuro: non-focal pertinent results: on pt underwent a flexible bronchoscopy showing thick secretions in all airways (bloody in rul), severe tbm in r and l ms bronchi as well as a focal area of increased malacia in mid-trachea brief hospital course: pt was admitted to interventional pulmonology on for inability to decannulate her tracheostomy as well as evaluation of tracheo bronchomalacia. on arrival pt was admitted to the icu and noted to have shortness of breath and orthopnea. pt had been started on prednisone and was switched to solu-medrol on admission. ceftazidime and clindamycin were also started upon admission for pneumonia. on pt underwent a flexible bronchoscopy showing thick secretions in all airways (bloody in rul), severe tbm in r and l ms bronchi as well as a focal area of increased malacia in mid-trachea. pt tolerated the procedure well and was transferred to the surgical floor later that day. on pt underwent flexible and rigid bronchoscopy with y-stent placement and trach stent as well as tracheostomy tube replacement. pt was transferred to the icu on for increased pco2 on abg for which she was placed on bipap. on pt was doing well, she once again underwent a flexible bronchoscopy with exchange of tracheostomy tube to #7 cuffed tube. pt was transferred to hospital on medications on admission: meds at home: oxycontin 30", protonix 40', duragesic 100mcg q72h, lasix 60', coumadin 2', robaxin 500' x 10d, glimepiride 4", duoneb q6, klor 20", klonopin 1', percocet prn, combivent prn, mylanta prn, albuterol prn, proventil prn, ferrous sulfate 325', cardizem 360' meds on transfer: compazine prn, lopressor 50", prednisone 20", lovenox 130", lasix 60', neurontin 300", ativan prn, oxycontin 30", ferrous sulfate 325', cardizem 360', clonazepam 1', xopenex prn, atrovent prn, ng 0.4 prn, lantus 20u qhs, clinda 600''' (), ceftaz 1''' (), prochlorperazine prn, iss, duragesic 100mcg q72h, protonix 40', klor 20" discharge medications: 1. prednisone 20 mg tablet sig: one (1) tablet po daily (daily). 2. gabapentin 300 mg capsule sig: one (1) capsule po bid (2 times a day). 3. lorazepam 0.5 mg tablet sig: one (1) tablet po q4h (every 4 hours) as needed. 4. oxycodone 30 mg tablet sustained release 12 hr sig: one (1) tablet sustained release 12 hr po every twelve (12) hours. 5. ferrous sulfate 325 mg (65 mg iron) tablet sig: one (1) tablet po daily (daily). 6. diltiazem hcl 360 mg capsule, sust. release 24 hr sig: one (1) capsule, sust. release 24 hr po daily (daily). 7. clonazepam 1 mg tablet sig: one (1) tablet po qhs (once a day (at bedtime)) as needed. 8. guaifenesin 1,200 mg tablet sustained release 12 hr sig: one (1) tablet sustained release 12 hr po bid (2 times a day). 9. nitroglycerin 0.4 mg tablet, sublingual sig: one (1) tablet, sublingual sublingual prn (as needed). 10. ipratropium bromide 0.02 % solution sig: 0.2 mg/ml inhalation q6h (every 6 hours). 11. benzonatate 100 mg capsule sig: one (1) capsule po tid (3 times a day). 12. fentanyl 100 mcg/hr patch 72 hr sig: one (1) patch 72 hr transdermal q72h (every 72 hours). 13. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q24h (every 24 hours). 14. albuterol sulfate 2.5 mg/3 ml solution for nebulization sig: 2.5mg/3ml mg/ml inhalation q2h (every 2 hours) as needed. 15. metoprolol tartrate 50 mg tablet sig: one (1) tablet po bid (2 times a day). 16. acetylcysteine 20 % (200 mg/ml) solution sig: 1-2 mls miscellaneous q6h (every 6 hours). 17. enoxaparin 150 mg/ml syringe sig: one (1) subcutaneous q12h (every 12 hours). 18. guaifenesin 600 mg tablet sustained release sig: two (2) tablet sustained release po bid (2 times a day). 19. insulin riss 20. clindamycin phosphate 600 mg/4 ml solution sig: one (1) intravenous every eight (8) hours. 21. ceftazidime 1 gram recon soln sig: one (1) recon soln intravenous q8h (every 8 hours). discharge disposition: extended care facility: hospital discharge diagnosis: trachaelbronchomalacia s/p y stent trach (7 years ago, failed to extubate p hip surgery), copd, djd, mrsa pna (), vtach (), atrial stenosis, diabetes mellitus t2 gerds, a. flutter s/p cardioversion, pulmonary embolism s/p multiple hip surgeries right leg hematoma evacuation +ab for transfusions discharge condition: stable, deconditioned discharge instructions: call dr. office if experience: -fever > 101 or chills -increased cough, shortness of breath, or sputum production -chest pain continue guaifenesin 1200mg twice daily while stent in place. followup instructions: follow-up with dr. office in 4 weeks follow-up with your pcp md procedure: other intubation of respiratory tract closed [endoscopic] biopsy of bronchus bronchoscopy through artificial stoma bronchoscopy through artificial stoma replacement of tracheostomy tube replacement of tracheostomy tube replacement of tracheostomy tube diagnoses: obstructive sleep apnea (adult)(pediatric) esophageal reflux diabetes mellitus without mention of complication, type ii or unspecified type, not stated as uncontrolled chronic airway obstruction, not elsewhere classified atrial fibrillation aortic valve disorders personal history of tobacco use atrial flutter osteoarthrosis, unspecified whether generalized or localized, site unspecified personal history of venous thrombosis and embolism tracheostomy status other diseases of trachea and bronchus pain in limb other acute postoperative pain 

Answer: The patient is high likely exposed to